Analysing Reported FDA Adverse Events of Consumer Products

Inspiration

Our primary inspiration stemmed from the crucial role the Food and Drug Administration (FDA) plays in safeguarding public health. The realization that data, specifically from the FDA's Center for Food Safety and Applied Nutrition (CFSAN) Adverse Event Reporting System (CAERS), could be pivotal in identifying and mitigating risks associated with consumer products, motivated our efforts. This project was driven by the ambition to uncover patterns and insights that could potentially enhance consumer safety and inform regulatory actions.

What It Does

Our project, "Analysing Reported FDA Adverse Events of Consumer Products," meticulously analyzes the CAERS data to identify potentially dangerous consumer products. By leveraging advanced data analytics techniques, we examine adverse event reports and medical outcomes associated with these products. Our analysis provides a nuanced understanding of the demographics involved in these events, leading to the identification of products or categories that exhibit safety concerns.

How We Built It

We built our solution using a comprehensive data science approach. Key steps included:

1. Data Preprocessing: Cleaning and structuring the Product-Based CAERS data, ensuring it was suitable for analysis.
2. Feature Selection and Engineering: Choosing relevant features and, where necessary, transforming them (e.g., one-hot encoding of categorical variables).
3. Exploratory Data Analysis (EDA): Conducting in-depth EDA to understand distributions, patterns, and relationships within the data.
4. Modeling: Implementing models like decision trees to group similar cases and predict outcomes.
5. Visualization: Using various plotting techniques, including heatmaps, histograms, and donut charts, to visualize our findings.

Challenges We Ran Into

Our journey wasn't without its challenges. Key obstacles included handling the large volume of data and ensuring accurate one-hot encoding of categorical variables. Overcoming these challenges required innovative data sampling strategies, rigorous data validation, and fine-tuning our analysis techniques.

Accomplishments That We're Proud Of

We're particularly proud of:

• Successfully managing and analyzing a large and complex dataset.
• Developing a system that could potentially inform crucial FDA regulatory decisions.
• Gaining deep insights into adverse event patterns and demographics.
• Enhancing our technical proficiency in data science methodologies.

What We Learned

This project was a profound learning experience, deepening our understanding of:

• The intricacies of FDA’s CAERS data and its implications for public health.
• Advanced data analysis techniques and their real-world applications.
• The importance of data quality and preprocessing in deriving accurate insights.
• Collaborative problem-solving and the value of persistence in the face of technical challenges.

Built With

• colab
• matplotlib
• numpy
• python
• seaborn
• sklearn